We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ASLN market cap is 1.7M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| TWD (TWD) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 12M | 0 | 0 | 0 |
| Operating Income | -18.11M | -2.36M | -10.42M | -12.85M | -9.29M |
| Net Income | -19.11M | -1.89M | -9.71M | -13.51M | -9.92M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| TWD (TWD) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 92.36M | 0 | 0 | 0 | 12M |
| Operating Income | -1.41B | -16.48M | -34.25M | -48.32M | -43.74M |
| Net Income | -1.45B | -16.2M | -31.59M | -51.38M | -44.22M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| TWD (TWD) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 60.32M | 55.21M | 44.64M | 24.63M | 20.99M |
| Total Liabilities | 50.43M | 48.84M | 45.52M | 37.91M | 38.95M |
| Total Equity | 9.89M | 6.37M | -882k | -13.29M | -17.97M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| TWD (TWD) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 699.39M | 16.08M | 94.52M | 61.19M | 24.63M |
| Total Liabilities | 717.46M | 26.23M | 37.21M | 52.82M | 37.91M |
| Total Equity | -18.07M | -10.15M | 57.3M | 8.37M | -13.29M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| TWD (TWD) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -37.33M | N/A | -46.64M | N/A |
| Investing | N/A | 270k | N/A | 269k | N/A |
| Financing | N/A | 21.1M | N/A | 10.72M | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| TWD (TWD) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -796.12M | -15.05M | -34M | -38.41M | -46.64M |
| Investing | 167k | 1,000 | -28k | 415k | 269k |
| Financing | 583.68M | 7.17M | 109.87M | 4.72M | 10.72M |
| Market Cap | 1.7M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 2.83M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | ASLAN Pharmaceuticals Ltd |
| Address |
190 elgin avenue george town 1-9005 |
| Website | https://www.aslanpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
